CL2007003553A1 - Uso de epotilonas para tratar enfermedades asociadas con un desequilibrio entre la actividad osteoblastica y osteoclastica. - Google Patents

Uso de epotilonas para tratar enfermedades asociadas con un desequilibrio entre la actividad osteoblastica y osteoclastica.

Info

Publication number
CL2007003553A1
CL2007003553A1 CL200703553A CL2007003553A CL2007003553A1 CL 2007003553 A1 CL2007003553 A1 CL 2007003553A1 CL 200703553 A CL200703553 A CL 200703553A CL 2007003553 A CL2007003553 A CL 2007003553A CL 2007003553 A1 CL2007003553 A1 CL 2007003553A1
Authority
CL
Chile
Prior art keywords
epotilones
osteoblastic
balance
diseases associated
treat diseases
Prior art date
Application number
CL200703553A
Other languages
English (en)
Inventor
Sanna Kakonen Dr Jens Hoffm Dr
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38008136&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007003553(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CL2007003553A1 publication Critical patent/CL2007003553A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL200703553A 2006-12-08 2007-12-07 Uso de epotilonas para tratar enfermedades asociadas con un desequilibrio entre la actividad osteoblastica y osteoclastica. CL2007003553A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06025424A EP1930004A1 (en) 2006-12-08 2006-12-08 Use of epothilones in the treatment of osteoporosis and related diseases

Publications (1)

Publication Number Publication Date
CL2007003553A1 true CL2007003553A1 (es) 2008-07-04

Family

ID=38008136

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200703553A CL2007003553A1 (es) 2006-12-08 2007-12-07 Uso de epotilonas para tratar enfermedades asociadas con un desequilibrio entre la actividad osteoblastica y osteoclastica.

Country Status (15)

Country Link
US (1) US20080146626A1 (es)
EP (2) EP1930004A1 (es)
KR (1) KR20090087038A (es)
CN (1) CN101553227A (es)
AR (1) AR064214A1 (es)
AU (1) AU2007327767A1 (es)
BR (1) BRPI0719997A2 (es)
CA (1) CA2672114A1 (es)
CL (1) CL2007003553A1 (es)
IL (1) IL198493A0 (es)
MX (1) MX2009006074A (es)
TW (1) TW200829239A (es)
UY (1) UY30769A1 (es)
WO (1) WO2008068043A1 (es)
ZA (1) ZA200904755B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3566719A1 (en) 2010-05-18 2019-11-13 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
RU2496511C1 (ru) * 2012-04-20 2013-10-27 Замертон Холдингс Лимитед Фармацевтическая композиция, средство (варианты) и способ профилактики и лечения артрита, остеоартроза и остеохондроза позвоночника (варианты)
AU2016340093A1 (en) 2015-10-16 2018-05-10 William Marsh Rice University Epothilone analogs, methods of synthesis, methods of treatment, and drug conjugates thereof
CN110974824A (zh) * 2019-12-18 2020-04-10 中国人民解放军陆军军医大学第一附属医院 埃博霉素b在制备防治炎症性骨丢失药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6320045B1 (en) * 1997-12-04 2001-11-20 Bristol-Myers Squibb Company Process for the reduction of oxiranyl epothilones to olefinic epothilones
US6893859B2 (en) * 2001-02-13 2005-05-17 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
WO2002080846A2 (en) * 2001-04-03 2002-10-17 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
EP1640004A1 (en) * 2004-09-24 2006-03-29 Schering Aktiengesellschaft Use of epothilones in the treatment of bone metastases and bone tumors or cancers
US20060069136A1 (en) * 2004-09-24 2006-03-30 Ulrich Klar Use of Epothilones in the treatment of bone metastasis

Also Published As

Publication number Publication date
WO2008068043A1 (en) 2008-06-12
IL198493A0 (en) 2010-02-17
AR064214A1 (es) 2009-03-18
EP2101765A1 (en) 2009-09-23
CN101553227A (zh) 2009-10-07
AU2007327767A1 (en) 2008-06-12
BRPI0719997A2 (pt) 2014-03-18
US20080146626A1 (en) 2008-06-19
EP1930004A1 (en) 2008-06-11
ZA200904755B (en) 2010-09-29
MX2009006074A (es) 2009-08-24
CA2672114A1 (en) 2008-06-12
TW200829239A (en) 2008-07-16
UY30769A1 (es) 2008-07-31
KR20090087038A (ko) 2009-08-14

Similar Documents

Publication Publication Date Title
CL2008000947A1 (es) Uso de un antagonista de la proteina beta-klotho (klb) para tratar trastornos asociados a la expresion o actividad de klb.
CL2007002837A1 (es) Uso de fenitoina para tratar mucositis oral.
GT200800250A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
CL2008000791A1 (es) Compuestos derivados de 2-amino-5-(4-difluorometoxi-fenil)-5-fenil-imidazolidin-4-ona; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de una enfermedad asociada con la actividad bace excesiva, tales como enferm
MA28489B1 (fr) Preparations pharmaceutiques
CL2008000593A1 (es) Uso de compuestos derivados de heterociclos sustituidos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad aterosclerotica de las arterias entre otras enfermedades.
ATE482618T1 (de) Wirkstoffkombinationen
ATE484194T1 (de) Wirkstoffkombinationen
CL2009001099A1 (es) Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune.
UA94221C2 (en) Lipocalin protein
BRPI0614159A2 (pt) implemento para cuidado oral
BRPI0813955A2 (pt) composições terapêuticas e o uso das mesmas
CL2008000594A1 (es) Uso de compuestos derivados de heterociclos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad arterial coronaria entre otras enfermedades.
CR10725A (es) Compuestos de pirazolina y su uso y composiones farmaceuticas
BRPI0813456A2 (pt) Composto, uso do mesmo, composição farmacêutica, e, métodos para tratar um mamífero sofrendo de um distúrbio e de uma doença
PA8657801A1 (es) Aminalcoholes triciclicos, procedimientos para su preparacion
BRPI0814931A2 (pt) Composto com atividade contra hcv, sua composição e seu uso
BRPI0818766A2 (pt) N-fenil-pirrolidinilmetilpirrolidinamidas substituídas e uso terapêutico das mesmas
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
CL2007003553A1 (es) Uso de epotilonas para tratar enfermedades asociadas con un desequilibrio entre la actividad osteoblastica y osteoclastica.
BRPI0920878A2 (pt) inbidor de ksp161 para aumentar apoptose, sua administração e seu uso.
DK2119472T3 (da) Hud-/hårbehandlingssystem
UY33662A (es) Combinaciones que comprenden inhibidores de dhodh e inhibidores de cox
DK2049092T3 (da) Præparater med forbedret elastiserende aktivitet
FI20050453A0 (fi) Ihonhoitokoostumus